Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gregoire Stalder
Immune Checkpoint Inhibition in Classical Hodgkin Lymphoma: From Early Achievements Towards New Perspectives
Journal of Oncology
Oncology
Related publications
Retreatment With Nivolumab in Patients With R/R Classical Hodgkin Lymphoma After Discontinuation of the Therapy With Immune Checkpoint Inhibitors
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Lymphocyte-Rich Classical Hodgkin Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Circulating Dendritic Cells Deficiencies as a New Biomarker in Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
An Anaplastic T-Cell Lymphoma Mimicking Classical Hodgkin Lymphoma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Immune Checkpoint Inhibition: From Molecules to Clinical Application
Clinical and Experimental Immunology
Allergy
Immunology
Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma
Case Reports in Hematology
Novel Therapeutic Agents for Relapsed Classical Hodgkin Lymphoma
British Journal of Haematology
Hematology
EBV-Positive Plasmablastic Lymphoma Mimicking Reactive Lymphadenopathy Versus Recurrent Hodgkin Lymphoma Following Chemotherapy for Stage II Classical Hodgkin Lymphoma
Journal of Tumour Research & Reports
Chemotherapy and Radiation Improve Survival in Early Stage Classical Hodgkin Lymphoma: A Statewide Cancer Registry Analysis
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
